BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29450608)

  • 1. Imaging findings of ovarian dysgerminoma with emphasis on multiplicity and vascular architecture: pathogenic implications.
    Tsuboyama T; Hori Y; Hori M; Onishi H; Tatsumi M; Sakane M; Ota T; Tomiyama N
    Abdom Radiol (NY); 2018 Jul; 43(7):1515-1523. PubMed ID: 29450608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pure dysgerminoma of the ovary: CT and MRI features with pathological correlation in 13 tumors.
    Zhao S; Sun F; Bao L; Chu C; Li H; Yin Q; Guan W; Wang D
    J Ovarian Res; 2020 Jun; 13(1):71. PubMed ID: 32552845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of pure ovarian dysgerminoma: a series of eight cases.
    Cacioppa LM; Crusco F; Marchetti F; Duranti M; Renzulli M; Golfieri R
    Cancer Imaging; 2021 Oct; 21(1):58. PubMed ID: 34711293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Computed Tomography Features of Female Pelvic Malignant Germ Cell Tumors in Children and Adolescents: A Series of 30 Cases.
    Wang Q; Yu D; Wang F
    J Pediatr Adolesc Gynecol; 2020 Feb; 33(1):83-88. PubMed ID: 31627179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OCT4: a novel biomarker for dysgerminoma of the ovary.
    Cheng L; Thomas A; Roth LM; Zheng W; Michael H; Karim FW
    Am J Surg Pathol; 2004 Oct; 28(10):1341-6. PubMed ID: 15371950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
    Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
    PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian dysgerminoma: MR and CT appearance.
    Tanaka YO; Kurosaki Y; Nishida M; Michishita N; Kuramoto K; Itai Y; Kubo T
    J Comput Assist Tomogr; 1994; 18(3):443-8. PubMed ID: 8188914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadoblastoma with dysgerminoma in one ovary and gonadoblastoma with dysgerminoma and yolk sac tumor in the contralateral ovary in a girl with 46XX karyotype.
    Obata NH; Nakashima N; Kawai M; Kikkawa F; Mamba S; Tomoda Y
    Gynecol Oncol; 1995 Jul; 58(1):124-8. PubMed ID: 7789879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadoblastoma: evidence for a stepwise progression to dysgerminoma in a dysgenetic ovary.
    Pauls K; Franke FE; Büttner R; Zhou H
    Virchows Arch; 2005 Sep; 447(3):603-9. PubMed ID: 15968543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian dysgerminoma: color Doppler ultrasonographic findings and comparison with CT and MR imaging findings.
    Kim SH; Kang SB
    J Ultrasound Med; 1995 Nov; 14(11):843-8. PubMed ID: 8551550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian dysgerminoma: clues to the radiological diagnosis.
    Amante S; Félix A; Cunha TM
    Diagn Interv Radiol; 2023 Jan; 29(1):18-23. PubMed ID: 36959710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas.
    Buell-Gutbrod R; Ivanovic M; Montag A; Lengyel E; Fadare O; Gwin K
    Pediatr Dev Pathol; 2011; 14(5):391-5. PubMed ID: 21682576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadoblastoma with contralateral dysgerminoma in a young female--a case report.
    Jadhav MN; Yelikar BR; Karigoudar M
    Indian J Pathol Microbiol; 2006 Apr; 49(2):274-6. PubMed ID: 16933739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of gynecological disease (6): clinical and ultrasound characteristics of ovarian dysgerminoma.
    Guerriero S; Testa AC; Timmerman D; Van Holsbeke C; Ajossa S; Fischerova D; Franchi D; Leone FP; Domali E; Alcazar JL; Parodo G; Mascilini F; Virgilio B; Demidov VN; Lipatenkova J; Valentin L
    Ultrasound Obstet Gynecol; 2011 May; 37(5):596-602. PubMed ID: 21305635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of SALL4 and SF-1 in gonadoblastoma: useful markers in the identification of the invasive germ cell component.
    Bai S; Wei S; Ziober A; Yao Y; Bing Z
    Int J Gynecol Pathol; 2013 Jul; 32(4):379-83. PubMed ID: 23722510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of ovarian dysgerminoma to yolk sac tumor: evidence for a histogenetic continuum.
    Parkash V; Carcangiu ML
    Mod Pathol; 1995 Oct; 8(8):881-7. PubMed ID: 8552580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral ovarian gonadoblastoma with coexisting dysgerminoma in a girl with 46, XX karyotype.
    Yilmaz B; Gungor T; Bayramoglu H; Soysal S; Mollamahmutoglu L
    J Obstet Gynaecol Res; 2010 Jun; 36(3):697-700. PubMed ID: 20598061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadoblastoma; a gonadal tumor related to the dysgerminoma (seminoma) and capable of sex-hormone production.
    SCULLY RE
    Cancer; 1953 May; 6(3):455-63. PubMed ID: 13042769
    [No Abstract]   [Full Text] [Related]  

  • 20. Ovarian collision tumors: imaging findings, pathological characteristics, diagnosis, and differential diagnosis.
    Peng Y; Lin J; Guan J; Chen L; Zhang X; Li S; Wang H; Liu M; Guo Y
    Abdom Radiol (NY); 2018 Aug; 43(8):2156-2168. PubMed ID: 29198011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.